Grosu A, Strahlenther Onkol 2005
FDG-PET
•
T-Staging:
Detection
•
Sensitivity
localized disease
67%
advanced disease
92%
•
Limitations
–
Low glucose uptake
–
Large overlap between tumor and benign hyperplasia
–
Renal excretion of FDG into the bladder




